SELLAS Life Sciences Group (SLS) SEC Filings: History & Chart

SELLAS Life Sciences Group, Inc.(SLS)

Biotechnology · New York, NY

$11.34-0.29 (-2.49%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About SELLAS Life Sciences Group, Inc.

SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a peptide immunotherapy directed against the Wilms tumor 1, antigen; and SLS009 (tambiciclib), a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors; GenFleet Therapeutics (Shanghai), Inc. for the development and commercialization of GFH009; and Memorial Sloan Kettering Cancer Center for developing and commercializing MSK's WT1 peptide vaccine technology. SELLAS Life Sciences Group, Inc. is headquartered in New York, New York.

New York, NY

13 employees

www.sellaslifesciences.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Angelos Stergiou

View full financials

Form	Filing Date	Accepted	Document
8-K	Aug 11, 2026	Aug 11, 2026	View filing
10-Q	Aug 11, 2026	Aug 11, 2026	View filing
SC 13G	Aug 7, 2026	Aug 7, 2026	View filing
SC 13G	Jul 31, 2026	Jul 31, 2026	View filing
8-K	Jul 27, 2026	Jul 27, 2026	View filing
8-K	Jun 25, 2026	Jun 25, 2026	View filing
8-K	Jun 18, 2026	Jun 18, 2026	View filing
4	Jun 18, 2026	Jun 18, 2026	View filing
S-8	Jun 16, 2026	Jun 16, 2026	View filing
8-K	Jun 2, 2026	Jun 2, 2026	View filing
8-K	May 12, 2026	May 12, 2026	View filing
10-Q	May 12, 2026	May 12, 2026	View filing
SC 13G/A	Apr 24, 2026	Apr 24, 2026	View filing
ARS	Apr 23, 2026	Apr 23, 2026	View filing
DEFA14A	Apr 23, 2026	Apr 23, 2026	View filing
DEF 14A	Apr 23, 2026	Apr 23, 2026	View filing
SC 13G/A	Mar 27, 2026	Mar 27, 2026	View filing
S-3ASR	Mar 20, 2026	Mar 20, 2026	View filing
8-K	Mar 19, 2026	Mar 19, 2026	View filing
10-K	Mar 19, 2026	Mar 19, 2026	View filing
8-K	Mar 11, 2026	Mar 11, 2026	View filing
SC 13G/A	Feb 17, 2026	Feb 17, 2026	View filing
SC 13G/A	Jan 30, 2026	Jan 30, 2026	View filing
4	Jan 9, 2026	Jan 9, 2026	View filing
4	Jan 9, 2026	Jan 9, 2026	View filing
4	Jan 9, 2026	Jan 9, 2026	View filing
4	Jan 9, 2026	Jan 9, 2026	View filing
4	Jan 9, 2026	Jan 9, 2026	View filing
4	Jan 9, 2026	Jan 9, 2026	View filing
4	Jan 9, 2026	Jan 9, 2026	View filing

SEC Filings

Recent Filings